NUGEN MEDICAL DEVICES INC (NGMD.CA) Stock Fundamental Analysis

Canada • TSX Venture Exchange • TSX-V:NGMD • CA67054F1009

0.035 CAD

+0.01 (+16.67%)

Last: Jan 30, 2026, 07:00 PM

Fundamental Rating

NGMD gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of NGMD have multiple concerns. NGMD is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NGMD has reported negative net income.
NGMD had a negative operating cash flow in the past year.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	-16.43%
ROE	N/A
ROIC	N/A

ROA(3y)-85.48%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

NGMD's Gross Margin has declined in the last couple of years.
NGMD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	54.96%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-8.27%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NGMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NGMD has more shares outstanding
NGMD has a worse debt/assets ratio than last year.

2.2 Solvency

NGMD has an Altman-Z score of -3.23. This is a bad value and indicates that NGMD is not financially healthy and even has some risk of bankruptcy.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-3.23

ROIC/WACCN/A

WACC5.73%

2.3 Liquidity

A Current Ratio of 5.84 indicates that NGMD has no problem at all paying its short term obligations.
A Quick Ratio of 5.60 indicates that NGMD has no problem at all paying its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	5.84
Quick Ratio	5.6

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 76.63% over the past year.
Looking at the last year, NGMD shows a very negative growth in Revenue. The Revenue has decreased by -22.72% in the last year.
The Revenue has been growing by 94.29% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)76.63%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%39.71%

Revenue 1Y (TTM)-22.72%

Revenue growth 3Y94.29%

Revenue growth 5YN/A

Sales Q2Q%-93.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.